Like it or not, biologists have to deal increasingly in informatics as their experiments generate ever larger and more complex data sets. Few laboratories have the resources to develop their own ...

Genomatix Software GmbH today announced that it has achieved GeneChip-compatible TM status for several products with the Affymetrix Inc. (Nasdaq: AFFX) GeneChip® microarray platform and that it has ...

Affymetrix Inc. has announced the launch of Affymetrix University, a series of hands-on data analysis training courses that will be held in various locations throughout Europe and North America.

Affymetrix Inc. has announced the publication of the MicroArray Quality Control (MAQC) study, a collaborative effort led by the FDA that included 137 scientists from private and public sector ...

VICTORIA, BC, Sept. 5 /PRNewswire/ - GenoLogics, a leading developer oflab and data management software solutions for life sciences research,announced today the Company has joined the Affymetrix ...

Affymetrix Inc. announced that the US Food and Drug Administration (FDA) has granted regulatory clearance to its GCS3000Dx (GCSDx) platform for in vitro gene expression diagnostic testing. The ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix (Nasdaq:AFFX) and Ariosa Diagnostics, Inc. today announced the signing of a multi-year supply agreement covering Affymetrix arrays and instruments to ...

SANTA CLARA, USA: Affymetrix, Inc. announced a co-marketing agreement naming GenoSplice, Inc. as its preferred data analysis service provider for the new GeneChip Human Transcriptome Array 2.0, a ...

Research and Markets (http://www.researchandmarkets.com/research/7fhv5g/the_world_market) has announced the addition of the "The World Market for Microarrays" report ...